Expansion Growth National clinic footprint with multiple states and recent expansion history indicates room for cross-sell and channel partnerships, especially with clinics in AZ, CO, TX, MN, WA, IL, FL, and NV seeking scalable admin, scheduling, and telemedicine enhancements.

Integrated Therapy Diverse therapy offerings including NAD+ infusions and Spravato nasal spray show appetite for integrative treatment platforms; opportunity to upsell bundled programs, cross-promote with existing ketamine protocols, and introduce ancillary revenue streams.

Tech Enablement Active digital stack (Google Ads, JSON-LD, reCAPTCHA, Node.js, Nginx, analytics tags) suggests readiness for marketing automation, patient lifecycle campaigns, and secure online scheduling integrations to improve lead conversion and retention.

Strategic Partners Acquisition by Delic Holdings and collaboration with Ketamine Infusion Centers indicate potential for co-marketing, data sharing, and referral partnerships; explore alliance opportunities with related wellness and psychedelic treatment ecosystems.

Growth Finance Revenue in the low single-digit millions with a multi-clinic network and ongoing service innovations implies scalability opportunities through expanded payer partnerships, bundled payment options, and price-optimized service mix to boost margins.